Epidermal growth factor receptor (EGFR) exon 20 mutations in EGFR-tyrosine kinase inhibitors (EGFR-TKIs) naive non-small cell lung carcinoma (NSCLC) and response to erlotinib therapy
Bağlantı
http://hdl.handle.net/20.500.12627/107798https://doi.org/10.1200/jco.2018.36.15_suppl.e21212
Koleksiyonlar
- Makale [92796]